1.
Goh BC, Lehnert M, Lim HL, Ng AWK, Chan CC, Kong HL, et al. Phase II Trial of Docetaxel in Asian Patients with Inoperable Stage III Non-Small Cell Lung Cancer. AO [Internet]. 2000 Jan. 1 [cited 2024 Nov. 24];39(2):225-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/28142